Treatment challenges in Parkinson's disease.
Welsh
Mickie
M
The University of Southern California/Keck School of Medicine, Los Angeles, CA, USA.
D000465:Algorithms; D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use; D003142:Communication; D003266:Continuity of Patient Care; D003663:Decision Trees; D018450:Disease Progression; D015259:Dopamine Agents / Q000494:pharmacology / Q000627:therapeutic use; D016903:Drug Monitoring / Q000451:nursing; D006801:Humans; D007400:Interprofessional Relations; D007980:Levodopa / Q000494:pharmacology / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D009722:Nurse Practitioners / Q000458:organization & administration*; D024802:Nurse's Role; D009730:Nursing Assessment; D010300:Parkinson Disease / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D011320:Primary Health Care / Q000458:organization & administration*; D011795:Surveys and Questionnaires
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D008996:Monoamine Oxidase Inhibitors; D007980:Levodopa